Please provide your email address to receive an email when new articles are posted on . ASH issued guidelines for treatment of adolescents and young adults with ALL. The guidance includes ...
FDA cleared acalabrutinib plus venetoclax as the only all-oral, fixed-dose combination option for first-line, treatment-naïve CLL/SLL. Phase 3 AMPLIFY showed superior PFS versus chemoimmunotherapy, ...
Chronic lymphocytic leukemia (CLL), is a type of cancer that affects a type of white blood cell in your body called a lymphocyte. White blood cells are made in your bone marrow and help your body ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results